|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2005-9-23
|
|
pubmed:abstractText |
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommends long-acting bronchodilators as first-line maintenance treatment for patients with chronic obstructive pulmonary disease (COPD). A study was conducted comparing the long-acting anticholinergic tiotropium with the long-acting beta-agonist salmeterol to confirm the significant improvements in daytime bronchodilator efficacy seen with tiotropium in previous studies.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1094-5539
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
397-404
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16179215-Aged,
pubmed-meshheading:16179215-Albuterol,
pubmed-meshheading:16179215-Bronchodilator Agents,
pubmed-meshheading:16179215-Double-Blind Method,
pubmed-meshheading:16179215-Drug Administration Schedule,
pubmed-meshheading:16179215-Female,
pubmed-meshheading:16179215-Forced Expiratory Volume,
pubmed-meshheading:16179215-Humans,
pubmed-meshheading:16179215-Male,
pubmed-meshheading:16179215-Middle Aged,
pubmed-meshheading:16179215-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:16179215-Scopolamine Derivatives,
pubmed-meshheading:16179215-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD.
|
|
pubmed:affiliation |
University of Alabama at Birmingham, 459 Boshell Diabetes Building, 1808 7th Avenue South, Birmingham, AL, USA. dbriggs@chairdom.dom.uab.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
